OX Receptor
OX receptor (orexin receptor) is a G-protein coupled receptor that is involved in the regulation of feeding behaviour.
Products Related to OX Receptor(52)
- GC37623SeltorexantCAS: 1293281-49-8Purity: >98.00%
Seltorexant is an orally active, high-affinity, and selective OX2R antagonist with a pK i value of 8.1 for rat OX2R.
- GC38352Orexin A (human, rat, mouse) (TFA)Purity: >99.00%
Orexin A human, rat, mouse TFA, a 33 amino acid excitatory neuropeptide, orchestrates diverse central and peripheral processes.
- GC61770Orexin receptor antagonist 2CAS: 1457940-75-8Purity: >98.00%
Orexin receptor antagonist 2 (compound 30) is a potent orexin receptor antagonist with pKis of 7.69 and 9.78.
- GC63415JNJ-54717793CAS: 1628843-99-1Purity: >98.50%
JNJ-54717793, as a brain penetrant, is an orally active, selective and high affinity orexin-1 receptor (OX1R) antagonist (plasma EC50=85 ng/mL).
- GC64021Orexin B, rat, mouse TFAPurity: >98.50%
Orexin B, rat, mouse (Rat orexin B) TFA is an endogenous orexin receptor agonist.
- GC64826VornorexantCAS: 1517965-94-4Purity: >98%
Vornorexant (ORN-0829; TS-142) is a potent dual OX1R and OX2R antagonist with IC50 values of 1.05 nM and 1.27 nM, respectively.
- GC67929Orexin 2 Receptor Agonist 2CAS: 2114324-60-4Purity: >98.00%
Orexin 2 Receptor Agonist 2 is a selective orexin 2 receptor agonist.
- GC68909CudarolimabCAS: 2244739-29-3Purity: >95.00%
Cudarolimab (IBI101) is a fully human anti-OX40 (CD134, a co-stimulatory molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has anti-tumor activity and can be used in cancer-related research.
- GC70782FirazorextonCAS: 2274802-95-6Purity: >99.00%
Firazorexton (TAK-994 free base) is an orally active, brain-permeable orexin type 2 receptor (OX2R) agonist.
- GC70783Firazorexton hydrateCAS: 2861934-86-1Purity: >99.00%
Firazorexton hydrate (TAK-994) is a potent, brain-penetrant, and orally active orexin type 2 receptor (OX2R) agonist (EC50: 19 nM).
- GC70784(2R,3R)-FirazorextonCAS: 2692692-00-3Purity: >99.00%
(2R,3R)-Firazorexton ((2R,3R)-TAK-994 free base) is an isomer of Firazorexton .
- GC71209FazamorexantCAS: 1808918-69-5Purity: >99.00%
Fazamorexant (YZJ-1139) is a potent orexin receptor antagonist.
- GC72466Efizonerimod alfaCAS: 1635395-27-5Purity: >98.00%
Efizonerimod alfa is a potent monoclonal antibody OX40 activator.
- GC72472RevdofilimabCAS: 2230138-89-1Purity: >99.00%
Revdofilimab (ABBV-368) is a human IgG1 agonist monoclonal antibody against OX40.
- GC79277SolaprubartCAS: 3057433-10-7Purity: >99.50%
Solaprubart (STAR-0310) is a fully human IgG1 subtype monoclonal antibody targeting OX40 (CD134/TNFRSF4), with a K d of 7.2 nM.
- GC79278VedastotugCAS: 2878367-20-3Purity: >99.50%
Vedastotug is a human monoclonal antibody targeting TNFRSF4/OX40/CD134, with its corresponding isotype control being Human IgG1 kappa, Isotype Control [1] .
- GC79313Alixorexton enantiomerCAS: 2648350-16-5Purity: >99.00%
Alixorexton (ALKS 2680) enantiomer is the enantiomer of Alixorexton.
| Catalog No. | Product Name | CAS No. | Purity | Structure |
|---|---|---|---|---|
| GC37623 | Seltorexant | 1293281-49-8 | >98.00% | |
Seltorexant is an orally active, high-affinity, and selective OX2R antagonist with a pK i value of 8.1 for rat OX2R. | ||||
| GC38352 | Orexin A (human, rat, mouse) (TFA) | - | >99.00% | |
Orexin A human, rat, mouse TFA, a 33 amino acid excitatory neuropeptide, orchestrates diverse central and peripheral processes. | ||||
| GC50142 | ACT 462206 | 1361321-96-1 | >98% | |
Potent, dual orexin receptor antagonist | ||||
| GC50559 | YNT 185 | 1804978-82-2 | >98% | |
YNT 185 is a nonpeptide, selective orexin type-2 receptor (OX2R) agonist, with EC50s of 0.028 and 2.75 μM for OX2R and OX1R, respectively. | ||||
| GC61770 | Orexin receptor antagonist 2 | 1457940-75-8 | >98.00% | |
Orexin receptor antagonist 2 (compound 30) is a potent orexin receptor antagonist with pKis of 7.69 and 9.78. | ||||
| GC63415 | JNJ-54717793 | 1628843-99-1 | >98.50% | |
JNJ-54717793, as a brain penetrant, is an orally active, selective and high affinity orexin-1 receptor (OX1R) antagonist (plasma EC50=85 ng/mL). | ||||
| GC64021 | Orexin B, rat, mouse TFA | - | >98.50% | |
Orexin B, rat, mouse (Rat orexin B) TFA is an endogenous orexin receptor agonist. | ||||
| GC64826 | Vornorexant | 1517965-94-4 | >98% | |
Vornorexant (ORN-0829; TS-142) is a potent dual OX1R and OX2R antagonist with IC50 values of 1.05 nM and 1.27 nM, respectively. | ||||
| GC65382 | Orexin receptor antagonist 5 | 1352834-55-9 | >98% | |
| GC65550 | Danavorexton | 2114324-48-8 | >98% | |
Danavorexton is an orexin receptor agonist. | ||||
| GC67929 | Orexin 2 Receptor Agonist 2 | 2114324-60-4 | >98.00% | |
Orexin 2 Receptor Agonist 2 is a selective orexin 2 receptor agonist. | ||||
| GC67957 | Orexin A (human, rat, mouse) (acetate) | - | >98% | |
| GC68909 | Cudarolimab | 2244739-29-3 | >95.00% | |
Cudarolimab (IBI101) is a fully human anti-OX40 (CD134, a co-stimulatory molecule expressed by activated immune cells) antibody. Cudarolimab inhibits the binding of OX40 to its ligand OX40L. Cudarolimab has anti-tumor activity and can be used in cancer-related research. | ||||
| GC70782 | Firazorexton | 2274802-95-6 | >99.00% | |
Firazorexton (TAK-994 free base) is an orally active, brain-permeable orexin type 2 receptor (OX2R) agonist. | ||||
| GC70783 | Firazorexton hydrate | 2861934-86-1 | >99.00% | |
Firazorexton hydrate (TAK-994) is a potent, brain-penetrant, and orally active orexin type 2 receptor (OX2R) agonist (EC50: 19 nM). | ||||
| GC70784 | (2R,3R)-Firazorexton | 2692692-00-3 | >99.00% | |
(2R,3R)-Firazorexton ((2R,3R)-TAK-994 free base) is an isomer of Firazorexton . | ||||
| GC70995 | Nivasorexant | 1435480-40-2 | - | |
Nivasorexant is a potent orexin receptor antagonist. | ||||
| GC71209 | Fazamorexant | 1808918-69-5 | >99.00% | |
Fazamorexant (YZJ-1139) is a potent orexin receptor antagonist. | ||||
| GC71296 | RTIOXA-43 | 2832067-72-6 | >99.00% | |
RTIOXA-43 is a orexin receptor agonist with EC50s of 24 nM and 24 nM for OX2 and OX1 receptors, respectively. | ||||
| GC72466 | Efizonerimod alfa | 1635395-27-5 | >98.00% | |
Efizonerimod alfa is a potent monoclonal antibody OX40 activator. | ||||
| GC72472 | Revdofilimab | 2230138-89-1 | >99.00% | |
Revdofilimab (ABBV-368) is a human IgG1 agonist monoclonal antibody against OX40. | ||||
| GC79277 | Solaprubart | 3057433-10-7 | >99.50% | |
Solaprubart (STAR-0310) is a fully human IgG1 subtype monoclonal antibody targeting OX40 (CD134/TNFRSF4), with a K d of 7.2 nM. | ||||
| GC79278 | Vedastotug | 2878367-20-3 | >99.50% | |
Vedastotug is a human monoclonal antibody targeting TNFRSF4/OX40/CD134, with its corresponding isotype control being Human IgG1 kappa, Isotype Control [1] . | ||||
| GC79313 | Alixorexton enantiomer | 2648350-16-5 | >99.00% | |
Alixorexton (ALKS 2680) enantiomer is the enantiomer of Alixorexton. | ||||
